Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 6
2007 6
2008 5
2009 8
2010 10
2011 7
2012 14
2013 13
2014 9
2015 14
2016 16
2017 14
2018 19
2019 9
2020 16
Text availability
Article attribute
Article type
Publication date

Search Results

142 results
Results by year
Filters applied: . Clear all
Page 1
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma.
Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, Bayır H, Abhari BA, Angeli JPF, Choi SM, Meul E, Heyninck K, Declerck K, Chirumamilla CS, Lahtela-Kakkonen M, Van Camp G, Krysko DV, Ekert PG, Fulda S, De Geest BG, Conrad M, Kagan VE, Vanden Berghe W, Vandenabeele P, Vanden Berghe T. Hassannia B, et al. Among authors: De Geest BG. J Clin Invest. 2018 Aug 1;128(8):3341-3355. doi: 10.1172/JCI99032. Epub 2018 Jun 25. J Clin Invest. 2018. PMID: 29939160 Free PMC article.
Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses.
Nuhn L, De Koker S, Van Lint S, Zhong Z, Catani JP, Combes F, Deswarte K, Li Y, Lambrecht BN, Lienenklaus S, Sanders NN, David SA, Tavernier J, De Geest BG. Nuhn L, et al. Among authors: De Geest BG. Adv Mater. 2018 Nov;30(45):e1803397. doi: 10.1002/adma.201803397. Epub 2018 Oct 1. Adv Mater. 2018. PMID: 30276880
Engineering the immune system with particles, step-by-step.
De Geest BG. De Geest BG. Mol Immunol. 2018 Jun;98:25-27. doi: 10.1016/j.molimm.2018.02.015. Epub 2018 Mar 9. Mol Immunol. 2018. PMID: 29526503 Review.
Developments and future clinical outlook of taxane nanomedicines.
Louage B, De Wever O, Hennink WE, De Geest BG. Louage B, et al. Among authors: De Geest BG. J Control Release. 2017 May 10;253:137-152. doi: 10.1016/j.jconrel.2017.03.027. Epub 2017 Mar 20. J Control Release. 2017. PMID: 28336374 Review.
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction.
Tulkens J, Vergauwen G, Van Deun J, Geeurickx E, Dhondt B, Lippens L, De Scheerder MA, Miinalainen I, Rappu P, De Geest BG, Vandecasteele K, Laukens D, Vandekerckhove L, Denys H, Vandesompele J, De Wever O, Hendrix A. Tulkens J, et al. Among authors: De Geest BG. Gut. 2020 Jan;69(1):191-193. doi: 10.1136/gutjnl-2018-317726. Epub 2018 Dec 5. Gut. 2020. PMID: 30518529 Free PMC article. No abstract available.
Nanomedicine and macroscale materials in immuno-oncology.
Sun Q , Barz M , De Geest BG , Diken M , Hennink WE , Kiessling F , Lammers T , Shi Y . Sun Q , et al. Among authors: De Geest BG. Chem Soc Rev. 2019 Jan 2;48(1):351-381. doi: 10.1039/c8cs00473k. Chem Soc Rev. 2019. PMID: 30465669 Review.
pH-Degradable Mannosylated Nanogels for Dendritic Cell Targeting.
De Coen R, Vanparijs N, Risseeuw MD, Lybaert L, Louage B, De Koker S, Kumar V, Grooten J, Taylor L, Ayres N, Van Calenbergh S, Nuhn L, De Geest BG. De Coen R, et al. Among authors: De Geest BG. Biomacromolecules. 2016 Jul 11;17(7):2479-88. doi: 10.1021/acs.biomac.6b00685. Epub 2016 Jun 3. Biomacromolecules. 2016. PMID: 27231045
Well-Defined Polymer-Paclitaxel Prodrugs by a Grafting-from-Drug Approach.
Louage B, Nuhn L, Risseeuw MD, Vanparijs N, De Coen R, Karalic I, Van Calenbergh S, De Geest BG. Louage B, et al. Among authors: De Geest BG. Angew Chem Int Ed Engl. 2016 Sep 19;55(39):11791-6. doi: 10.1002/anie.201605892. Epub 2016 Aug 25. Angew Chem Int Ed Engl. 2016. PMID: 27560940
142 results
Jump to page
Feedback